guanethidine has been researched along with Age-Related Osteoporosis in 3 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-six adult male SD rats were randomly divided into the following four groups: sham surgery (Sham) group, guanethidine (GD) group, abdominal transverse aorta coarctation-induced heart failure + normal saline (TAC) group, and TAC + guanethidine (TAC + GD) group." | 4.31 | Bone mass loss in chronic heart failure is associated with sympathetic nerve activation. ( Fan, D; Guan, Z; Huang, J; Jia, J; Leng, H; Li, Z; Song, C; Xu, Y; Yuan, W; Zhang, C; Zhang, W; Zhu, J, 2023) |
| "Osteoporosis is one of the major health problems in our modern world." | 1.33 | Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. ( Denhardt, DT; Ezura, Y; Karsenty, G; Kondo, H; Nakashima, K; Nifuji, A; Noda, M; Rittling, SR; Takeda, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Z | 1 |
| Yuan, W | 1 |
| Jia, J | 1 |
| Zhang, C | 1 |
| Zhu, J | 1 |
| Huang, J | 1 |
| Zhang, W | 1 |
| Fan, D | 1 |
| Leng, H | 1 |
| Li, Z | 1 |
| Xu, Y | 1 |
| Song, C | 1 |
| Kondo, H | 1 |
| Nifuji, A | 1 |
| Takeda, S | 1 |
| Ezura, Y | 1 |
| Rittling, SR | 1 |
| Denhardt, DT | 1 |
| Nakashima, K | 1 |
| Karsenty, G | 1 |
| Noda, M | 1 |
| Procacci, P | 1 |
| Zoppi, M | 1 |
| Maresca, M | 1 |
3 other studies available for guanethidine and Age-Related Osteoporosis
| Article | Year |
|---|---|
Bone mass loss in chronic heart failure is associated with sympathetic nerve activation.
Topics: Animals; Guanethidine; Heart Failure; Male; Osteoporosis; Osteoprotegerin; RANK Ligand; Rats; Rats, | 2023 |
Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system.
Topics: Amino Acids; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Marrow Cells; Dopamine beta-Hydr | 2005 |
[Guanethidine therapy of reflex sympathetic syndromes].
Topics: Adult; Aged; Arterial Occlusive Diseases; Causalgia; Drug Evaluation; Edema; Female; Fibromyalgia; G | 1975 |